Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-03-28
2006-03-28
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S124000, C546S275400, C546S152000, C514S314000, C514S341000
Reexamination Certificate
active
07019005
ABSTRACT:
A class of pyrazole derivatives is described for use in treating p38 kinase mediated disorders. Compounds of particular interest are defined by Formula Iwherein R1, R2, Ar1and HetAr2are as described in the specification.
REFERENCES:
patent: 4000281 (1976-12-01), Beiler et al.
patent: 5932576 (1999-08-01), Anantanarayan et al.
patent: 6579873 (2003-06-01), Anantanarayan et al.
Hashimoto et al (1993): STN International CAPLUS database, (Columbus, Ohio), Accession No. 1993:472619.
Clare Michael
Geng Lifeng
Hanson Gunnar J.
Naraian Ashok S.
Partis Richard A.
Ashbrook Charles
G. D. Searle & Co.
Lappin Julie M.
Shameem Golam M. M.
LandOfFree
3 (5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3 (5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3 (5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3581467